CANCvsFMEDETF Comparison
Tema Oncology ETF (CANC) belongs to the Tomorrow's Treatments segment. Fidelity Disruptive Medicine ETF (FMED) is part of the Multiple Trends segment. Both ETFs have the same top 3 sector exposures: and Healthcare. CANC is more expensive with a Total Expense Ratio (TER) of 0.99%, versus 0.5% for FMED. CANC is up 18.41% year-to-date (YTD) with +$52M in YTD flows. FMED performs worse with 4.78% YTD performance, and -$17M in YTD flows. Run a side-by-side ETF comparison of CANC and FMED below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
CANC vs FMED performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | CANC FMED | -0.28%-0.72% | +8.61%+13.05% | +18.41%+4.78% | +53.77%+18.10% | n/a+13.64% | n/an/a |
| Flows | CANC FMED | -$2M- | +$3M-$17M | +$52M-$17M | +$76M-$14M | --$6M | -- |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | CANC FMED | +23.01%+22.48% | +22.71%+19.53% | n/a+18.59% | n/an/a |
| Max drawdown | CANC FMED | -5.93%-5.92% | -9.20%-17.78% | n/a-21.42% | n/an/a |
| Max drawdown duration | CANC FMED | 47d18d | 67d212d | n/a211d | n/an/a |
CANC | FMED | |
Last sale 7/28/2026 at 1:30 PM | $41.18 | |
| Previous close 07/27/2026 | $41.10 | |
| Consolidated volume 07/27/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
CANC | FMED | |
|---|---|---|
| Last price | $41.18 | – |
| 1D performance | +0.20% | – |
| AuM | $195.62 M | $46.10 M |
| E/R | 0.99% | 0.5% |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
